Cargando…

Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes

PURPOSE: Deep convolutional neural networks (CNN) provide high accuracy for automatic classification of dopamine transporter (DAT) SPECT images. However, CNN are inherently black-box in nature lacking any kind of explanation for their decisions. This limits their acceptance for clinical use. This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazari, Mahmood, Kluge, Andreas, Apostolova, Ivayla, Klutmann, Susanne, Kimiaei, Sharok, Schroeder, Michael, Buchert, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921148/
https://www.ncbi.nlm.nih.gov/pubmed/34651223
http://dx.doi.org/10.1007/s00259-021-05569-9
_version_ 1784669274766311424
author Nazari, Mahmood
Kluge, Andreas
Apostolova, Ivayla
Klutmann, Susanne
Kimiaei, Sharok
Schroeder, Michael
Buchert, Ralph
author_facet Nazari, Mahmood
Kluge, Andreas
Apostolova, Ivayla
Klutmann, Susanne
Kimiaei, Sharok
Schroeder, Michael
Buchert, Ralph
author_sort Nazari, Mahmood
collection PubMed
description PURPOSE: Deep convolutional neural networks (CNN) provide high accuracy for automatic classification of dopamine transporter (DAT) SPECT images. However, CNN are inherently black-box in nature lacking any kind of explanation for their decisions. This limits their acceptance for clinical use. This study tested layer-wise relevance propagation (LRP) to explain CNN-based classification of DAT-SPECT in patients with clinically uncertain parkinsonian syndromes. METHODS: The study retrospectively included 1296 clinical DAT-SPECT with visual binary interpretation as “normal” or “reduced” by two experienced readers as standard-of-truth. A custom-made CNN was trained with 1008 randomly selected DAT-SPECT. The remaining 288 DAT-SPECT were used to assess classification performance of the CNN and to test LRP for explanation of the CNN-based classification. RESULTS: Overall accuracy, sensitivity, and specificity of the CNN were 95.8%, 92.8%, and 98.7%, respectively. LRP provided relevance maps that were easy to interpret in each individual DAT-SPECT. In particular, the putamen in the hemisphere most affected by nigrostriatal degeneration was the most relevant brain region for CNN-based classification in all reduced DAT-SPECT. Some misclassified DAT-SPECT showed an “inconsistent” relevance map more typical for the true class label. CONCLUSION: LRP is useful to provide explanation of CNN-based decisions in individual DAT-SPECT and, therefore, can be recommended to support CNN-based classification of DAT-SPECT in clinical routine. Total computation time of 3 s is compatible with busy clinical workflow. The utility of “inconsistent” relevance maps to identify misclassified cases requires further investigation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-021-05569-9.
format Online
Article
Text
id pubmed-8921148
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-89211482022-03-17 Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes Nazari, Mahmood Kluge, Andreas Apostolova, Ivayla Klutmann, Susanne Kimiaei, Sharok Schroeder, Michael Buchert, Ralph Eur J Nucl Med Mol Imaging Original Article PURPOSE: Deep convolutional neural networks (CNN) provide high accuracy for automatic classification of dopamine transporter (DAT) SPECT images. However, CNN are inherently black-box in nature lacking any kind of explanation for their decisions. This limits their acceptance for clinical use. This study tested layer-wise relevance propagation (LRP) to explain CNN-based classification of DAT-SPECT in patients with clinically uncertain parkinsonian syndromes. METHODS: The study retrospectively included 1296 clinical DAT-SPECT with visual binary interpretation as “normal” or “reduced” by two experienced readers as standard-of-truth. A custom-made CNN was trained with 1008 randomly selected DAT-SPECT. The remaining 288 DAT-SPECT were used to assess classification performance of the CNN and to test LRP for explanation of the CNN-based classification. RESULTS: Overall accuracy, sensitivity, and specificity of the CNN were 95.8%, 92.8%, and 98.7%, respectively. LRP provided relevance maps that were easy to interpret in each individual DAT-SPECT. In particular, the putamen in the hemisphere most affected by nigrostriatal degeneration was the most relevant brain region for CNN-based classification in all reduced DAT-SPECT. Some misclassified DAT-SPECT showed an “inconsistent” relevance map more typical for the true class label. CONCLUSION: LRP is useful to provide explanation of CNN-based decisions in individual DAT-SPECT and, therefore, can be recommended to support CNN-based classification of DAT-SPECT in clinical routine. Total computation time of 3 s is compatible with busy clinical workflow. The utility of “inconsistent” relevance maps to identify misclassified cases requires further investigation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-021-05569-9. Springer Berlin Heidelberg 2021-10-15 2022 /pmc/articles/PMC8921148/ /pubmed/34651223 http://dx.doi.org/10.1007/s00259-021-05569-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Nazari, Mahmood
Kluge, Andreas
Apostolova, Ivayla
Klutmann, Susanne
Kimiaei, Sharok
Schroeder, Michael
Buchert, Ralph
Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes
title Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes
title_full Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes
title_fullStr Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes
title_full_unstemmed Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes
title_short Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes
title_sort explainable ai to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter spect in the diagnosis of clinically uncertain parkinsonian syndromes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921148/
https://www.ncbi.nlm.nih.gov/pubmed/34651223
http://dx.doi.org/10.1007/s00259-021-05569-9
work_keys_str_mv AT nazarimahmood explainableaitoimproveacceptanceofconvolutionalneuralnetworksforautomaticclassificationofdopaminetransporterspectinthediagnosisofclinicallyuncertainparkinsoniansyndromes
AT klugeandreas explainableaitoimproveacceptanceofconvolutionalneuralnetworksforautomaticclassificationofdopaminetransporterspectinthediagnosisofclinicallyuncertainparkinsoniansyndromes
AT apostolovaivayla explainableaitoimproveacceptanceofconvolutionalneuralnetworksforautomaticclassificationofdopaminetransporterspectinthediagnosisofclinicallyuncertainparkinsoniansyndromes
AT klutmannsusanne explainableaitoimproveacceptanceofconvolutionalneuralnetworksforautomaticclassificationofdopaminetransporterspectinthediagnosisofclinicallyuncertainparkinsoniansyndromes
AT kimiaeisharok explainableaitoimproveacceptanceofconvolutionalneuralnetworksforautomaticclassificationofdopaminetransporterspectinthediagnosisofclinicallyuncertainparkinsoniansyndromes
AT schroedermichael explainableaitoimproveacceptanceofconvolutionalneuralnetworksforautomaticclassificationofdopaminetransporterspectinthediagnosisofclinicallyuncertainparkinsoniansyndromes
AT buchertralph explainableaitoimproveacceptanceofconvolutionalneuralnetworksforautomaticclassificationofdopaminetransporterspectinthediagnosisofclinicallyuncertainparkinsoniansyndromes